
Breast cancer (BC) is a frequently diagnosed cancer in women worldwide and imposes a significant burden on healthcare systems. Although chemotherapy remains a primary treatment modality, its efficacy is often compromised by multidrug resistance (MDR), leading to poor clinical outcomes and treatment failure. Multidrug resistance in BC arises through multiple mechanisms, including decreased apoptotic activity, overexpression of ATP-binding cassette (ABC) transporters, alterations in the tumor microenvironment, enhanced DNA repair capacity, and epithelial–mesenchymal transition. Conventional chemotherapeutic agents such as doxorubicin and paclitaxel are effective against BC cells; however, their clinical utility is limited by MDR, severe side effects including cardiotoxicity and neuropathy, and reduced efficacy in resistant tumors. To address these challenges, natural products interfere with resistance mechanisms through diverse pathways, inhibiting efflux pumps such as P-glycoprotein, restoring apoptosis, and modulating signal transduction pathways, including PI3K/Akt and NF- κ B. Furthermore, they induce autophagy, inhibit unregulated cell growth, and modify the tumor microenvironment to enhance therapeutic response. Compounds such as curcumin, silybin, apigenin, berberine, matrine, and β -elemene have been shown to improve the effectiveness of chemotherapy, whether used as monotherapies or in combination with conventional drugs, while exhibiting minimal side effects compared to synthetic medicines. In conclusion, secondary metabolites derived from plants possess significant potential to overcome MDR in breast cancer. Their ability to attack resistance-related mechanisms through multiple pathways not only enhances the effectiveness of current therapy but also offers a promising source of safer and more effective anticancer agents.
Three-dimensional (3D) printing is a modern technique with great potential for a wide variety of applications. This technology has already demonstrated its potential in diverse fields such as biomedicine, construction, and food science. At present, 3D printing has also been explored in chemistry, particularly for the development of custom-supported catalysts. However, a major limitation of this approach is that commonly used printable materials generally lack intrinsic catalytic activity. Therefore, it is necessary to develop specific printable materials and to functionalize them to produce printed materials with catalytic activity. This drawback considerably reduces the potential of 3D printing for chemistry. To overcome this limitation, the present work investigates the catalytic potential of a commercially available 3D printing filament composed of polylactic acid loaded with colloidal copper. The catalytic performance of this material is evaluated using the copper-catalyzed Huisgen reaction as a model reaction, paying particular attention to the influence of reaction time and temperature.
Oxylipin research has undergone a profound transformation since the first discovery of an oxygenated metabolite of fatty acid, evolving from the identification of enzymatically produced lipid mediators to the study of complex bioactive lipid networks. The discovery of numerous non-enzymatic oxidation products has considerably expanded the oxylipin landscape, while advances in organic synthesis have enabled their syntheses as well as their structural characterization, stereochemical assignment, and biological investigations. Concurrently, developments in mass spectrometry and lipidomics have revolutionized oxylipin analysis, allowing the comprehensive profiling of hundreds of metabolites in a single injection setting. More recently, molecular networking has shifted the focus from individual compounds to interconnected lipid networks. This review highlights the major milestones that have shaped the field and discusses emerging strategies integrating chemistry, biology, analytical science, and computational approaches to accelerate the discovery of new bioactive oxylipins. The convergence of these disciplines is expected to drive predictive lipidomics, network-guided discovery and synthesis, and the development of more sustainable synthetic strategies for identifying and engineering the next generation of bioactive lipid mediators.
Zinquin (ZQ) is a small-molecule fluorescent probe used to monitor labile zinc in biological systems based on green fluorescence emission arising from the formation of [Zn(ZQ) 2 ] 2– complexes. However, studies in cells and protein-rich environments frequently report a pronounced blue-shifted emission, suggesting alternative interaction modes that complicate the interpretation of zinc imaging experiments. The nature of the interactions driving the blue shift is not fully understood. Here, we use the metallo-β-lactamase NDM-1 as a chemically and structurally well-defined model to elucidate the molecular origins of ZQ fluorescence in a zinc-binding protein. The NDM-1 has two distinct Zn 2+ ions in its active site, enabling direct assessment of zinc speciation, enzymatic activity, and structural integrity. Through an integrated approach combining fluorescence spectroscopy, enzyme activity assays, inductively coupled plasma mass spectrometry, X-ray absorption spectroscopy, and nuclear magnetic resonance, we identify two sources of ZQ fluorescence for this protein: formation of [Zn(ZQ) 2 ] 2– by stripping the weaker bound zinc, and a zinc-mediated ternary complex formed by NDM-1, Zn 2+ , and ZQ. This 1:1:1 complex localizes at the higher affinity zinc-binding site, where ZQ interacts concurrently with protein-bound zinc and specific residues of the NDM-1 active site. These nonpolar interactions generate a blue-shifted emission that is spectroscopically distinct from free zinc–ZQ complexes. This study characterizes the ternary complex that drives a protein-mediated fluorescence mechanism for ZQ and highlights the need to consider probe–protein interactions when interpreting fluorescent signals in chemical biology studies.
Mesoporous silica nanoparticles (MSNs) offer great potential to isolate and protect SOD-inspired Cu complexes from dissociation or hydrolysis during reaction with O 2 •− , and suitable pore and particle size can enhance SOD activity. Hence, controlling these two parameters is key for effective SOD mimicking. Herein, synthetic conditions were adjusted to prepare MSNs in the 100–250 nm range, with channels having an average width of 2.8 nm, which were used to host an imidazolate-bridged dicopper(II) complex [(μ-Im)Cu 2 (dien) 2 ] 3+ and two mononuclear Cu(II) complexes with flexible open-chain ligands, [Cu(salbn)] (salbn = 1,4-bis(salicylidenamino)butane) and [Cu(py 2 bn)] 2+ (py 2 bn = 1,4-bis(pyridin-2-ylmethyleneamino)butane). The effect on SOD activity of the resulting hybrids’ textural and morphological properties was examined. The combination of transmission and scanning electronic microscopies, dynamic light scattering, N 2 adsorption–desorption isotherms and reaction kinetics analyses reveals that reducing particle size improves catalytic activity as long as the particles are isolated and have morphological regularity, while the impact of pore width on SOD activity depends on the structural features of the catalyst and the constraints imposed by pore size on ligand rearrangement around the metal. These results demonstrate that controlling the morphology and texture of the material is a powerful tool for modulating the performance of SOD mimetic hybrids.